Patents by Inventor James C. Cusack

James C. Cusack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of NF-?B inhibition in combination therapy for cancer
    Patent number: 7700073
    Abstract: The use of NF-?B inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described.
    Type: Grant
    Filed: September 27, 2006
    Date of Patent: April 20, 2010
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Albert S. Baldwin, James C. Cusack, Marty W. Mayo, Cun-Yu Wang
  • Use of NF-B inhibition in combination therapy for cancer
    Patent number: 7700545
    Abstract: The use of NF-?B inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described.
    Type: Grant
    Filed: September 27, 2006
    Date of Patent: April 20, 2010
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Albert S. Baldwin, James C. Cusack, Marty W. Mayo, Cun-Yu Wang
  • Use NF-B inhibition in combination therapy for cancer
    Patent number: 7700543
    Abstract: The use of NF-?B inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described. When chemotherapeutic compounds and radiation activate NF-?B within cells, the cells are more resistant to the cytotoxic effects of these treatments. Inhibition of NF-?B activation is disclosed to provide a method to improve the efficacy of these cancer therapies.
    Type: Grant
    Filed: November 2, 2004
    Date of Patent: April 20, 2010
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Albert S. Baldwin, James C. Cusack, Marty W. Mayo, Cun-Yu Wang
  • Use of NF-&kgr;B inhibition in combination therapy for cancer
    Patent number: 6831057
    Abstract: The use of NF-&kgr;B inhibitors to enhance the cytotoxic effects of chemotherapy or radiation therapy in the treatment of neoplastic conditions is described.
    Type: Grant
    Filed: October 28, 1997
    Date of Patent: December 14, 2004
    Assignee: The University of North Carolina at Chapel Hill
    Inventors: Albert S. Baldwin, James C. Cusack, Marty W. Mayo, Cun-Yu Wang